CL - Colgate-Palmolive Company
| Previous close | 68.26 |
| Open | 68.25 |
| Bid | 66.51 x 1100 |
| Ask | 69.59 x 2200 |
| Day's range | 67.90 - 68.59 |
| 52-week range | 61.28 - 77.91 |
| Volume | 3,017,092 |
| Avg. volume | 3,331,554 |
| Market cap | 58.946B |
| Beta | 0.46 |
| PE ratio (TTM) | 27.19 |
| EPS (TTM) | 2.50 |
| Earnings date | 26 Oct 2018 |
| Forward dividend & yield | 1.68 (2.46%) |
| Ex-dividend date | 2018-10-18 |
| 1y target est | 69.11 |
Market Realist•2 days agoWhat Could Restrict the Upside in Kimberly-Clark Stock?
Shares of Kimberly Clark (KMB) have recovered a bit recently, as you can see in the graph below. The company’s decision to raise net pricing in the North American consumer product business is an encouraging move, likely to help the company offset the negatives stemming from continued inflation in raw material prices. Moreover, most of the company’s peers—including Procter & Gamble (PG), Colgate-Palmolive (CL), and Clorox (CLX)—are also raising prices to offset the impact of input cost headwinds.
Market Realist•3 days agoWhat’s Hurting Colgate-Palmolive Stock?
Colgate-Palmolive (CL), which has disappointed so far this year with its soft sales and tepid margins, further disheartened investors by reducing its sales and earnings outlook for 2018. Management now expects its top line to see low-single-digit growth, down from its earlier guidance of mid-single digit growth. Colgate-Palmolive’s top line is likely to benefit from the company’s recent acquisition in North America.
- Market Realist•3 days ago
PG, KMB, CL, CLX, and CHD: What Valuations and Ratings Suggest
Church & Dwight (CHD) is trading at a significant premium to its peer group average, reflecting the company’s outperformance on both the sales and earnings fronts over the past several quarters. However, given the recent uptrend in the stock and projected deceleration in the sales and earnings growth rate in fiscal 2019, the shares look fully priced. Church & Dwight stock trades at 26.1x and 24.3x its projected EPS of $2.28 and $2.45 in fiscal 2018 and fiscal 2019, respectively. The company’s high valuation could restrict the upside.
- Market Realist•3 days ago
Why Consumer Packaged Goods Stocks May Be Unattractive
Consumer packaged goods (or CPG) manufacturers haven’t had much to celebrate so far this year. Lower pricing amid intense competition in the value segment, a tough retail environment, and significant cost headwinds weighed on these companies’ financials and, in turn, their stock prices. Plus, macroeconomic challenges across several markets remained a drag.
Market Realist•14 days agoWill Procter & Gamble Stock Continue to Underperform?
Procter & Gamble (PG) stock has taken a beating in 2018. The weak top-line performance due to heightened competitive activity, pressure on the margins from the inflation in commodities, and higher shipping costs are taking a toll on Procter & Gamble’s financials. On a YTD basis, Kimberly-Clark, Clorox, and Colgate-Palmolive shares have declined 5.8%, 1.8%, and 13.5%, respectively.
Market Realist•15 days agoProcter & Gamble’s Bottom-Line Performance and Outlook
Procter & Gamble (PG) has a rich history of beating analysts’ EPS expectations. The company has surpassed analysts’ estimates in the past 13 quarters with an average surprise of 4.4%. The company’s commendable performance on the earnings front comes amid significant pressure on its sales and margins, which is commendable.
- Market Realist•15 days ago
Procter & Gamble’s Margins Could Remain Weak
Procter & Gamble (PG) has struggled on the margins front in the past several quarters. The following graph shows that the company’s core gross margin rate fell at an increased rate in the past four quarters, which isn’t a good sign. During the last reported quarter, Procter & Gamble’s core gross margin fell by ~140 basis points to 47.9%.
- Market Realist•15 days ago
Analysts Expect Procter & Gamble’s Sales to Remain Weak
Analysts expect Procter & Gamble (PG) to continue to disappoint investors with its sales performance in the first half of fiscal 2019. Analysts’ consensus estimate indicates a low single-digit decline in Procter & Gamble’s top line for the first two quarters of fiscal 2019. Analysts expect Procter & Gamble to report net sales of $16.6 billion and $17.3 billion in the first and second fiscal quarter, respectively.
- Market Realist•15 days ago
Procter & Gamble’s Valuation Doesn’t Look Attractive
Procter & Gamble's Valuation Doesn't Look AttractiveAnalysts’ target price indicates no upside
Market Realist•20 days agoHow Becton Dickinson Is Positioned Financially in August
Becton Dickinson (BDX) generated revenues of $4.3 billion in the fiscal third quarter compared to $1.5 billion in the fiscal third quarter of 2017, reflecting a ~41% YoY (year-over-year) growth. The acquisition of C.R. Bard primarily contributed to Becton Dickinson’s revenue growth in the third quarter.
Market Realist•last monthKimberly-Clark Stock Has Risen 10.5% since Its Q2 2018 Earnings
As of August 15, shares of Kimberly-Clark (KMB) have risen 10.5% since its second-quarter results on July 24. The primary reason for the recovery in the stock price is the anticipated increase in net selling prices. Kimberly-Clark’s management stated during the second-quarter conference call that it plans to increase pricing to offset the pressure on margins from continued inflation in commodity prices, including pulp.
Market Realist•last monthWhy Analysts Are Neutral on Church & Dwight Stock
A majority of analysts providing recommendations for Church & Dwight (CHD) stock have a “neutral” outlook, despite the company’s stellar financial performance in the first half of the year and its upbeat sales and earnings outlook. Church & Dwight stock was trading at a forward PE multiple of 23.8x, which is higher than most of its peers. Church & Dwight stock is also trading at a premium to the S&P 500 Index (SPY).
Market Realist•last monthWhat’s Driving Church & Dwight’s Earnings in 2018?
Church & Dwight’s (CHD) bottom line is growing at a rapid rate. In the first quarter of 2018, its adjusted earnings marked a 21.2% increase. Its second-quarter EPS grew 19.5%. Its strong sales and a significant decline in the tax rate have been driving its earnings higher.
Market Realist•last monthWhat’s behind Church & Dwight’s Strong Sales?
Church & Dwight (CHD) registered impressive sales growth in the past several quarters. The company’s top line has grown at a double-digit rate in the past four quarters, reflecting strong organic volumes and benefits from acquisitions. However, similar to its peers, pricing remained low and adversely impacted the top-line growth rate.
- Market Realist•last month
Church & Dwight Stock Sailing Smoothly, Peers Struggle
Why Church & Dwight Stock Is Outperforming Its Peers in 2018Strong H1 2018 financial performance
Market Realist•last monthWhy Analysts Are Neutral on PG, KMB, CL, and CLX
Most of the analysts continue to have a neutral outlook on the stocks of packaged goods manufacturers including Kimberly-Clark (KMB), Procter & Gamble (PG), Clorox (CLX), and Colgate-Palmolive (CL).
Market Realist•last monthWhat’s behind the Recent Recovery in Clorox Stock?
Clorox is one of only a few CPG companies that have managed to improve volumes as well as pricing. Other major CPG stocks like Procter & Gamble (PG), Kimberly-Clark (KMB), and Colgate-Palmolive (CL) have failed to improve pricing due to the heightened competitive environment. During the fiscal fourth quarter 2018 conference call, Clorox’s management stated that the company is increasing pricing in about 50% of its portfolio, which is expected to offset the negative impact from higher commodity costs.
Market Realist•last monthCould Colgate-Palmolive Stock See a Recovery in H2 2018?
Will These H1 2018 Stragglers Bounce Back in H2? Colgate-Palmolive’s (CL) first-half performance has been disheartening. Peers are no better, which is why Kimberly-Clark (KMB), Clorox (CLX), and Procter & Gamble (PG) are also trading in the red.
Market Realist•last monthWhy Costs and Currency Headwinds Could Hurt KMB Stock
Lower net selling prices, lower birth rates in South Korea, and macroeconomic challenges in Latin America subdued volumes and pricing. Also, weakness in the United States and competitive challenges in China further pressured the sales growth rate. The company’s second-half sales performance isn’t likely to be different as persisting headwinds could continue to hurt the top-line growth rate.
Market Realist•last monthWhat to Expect from Procter & Gamble in Fiscal 2019
Procter & Gamble (PG) managed to improve its net and organic sales growth rate in fiscal 2018 thanks to the favorable currency rates and higher volumes. Price investments to defend its market share in the grooming category and increased competition in the value segment restricted organic sales growth, which grew by only 1.0% in fiscal 2018. In the near term, pricing is expected to remain low and could adversely impact the organic sales growth rate.
Yahoo Finance•last monthStocks down amid crisis in Turkey
Yahoo Finance's LIVE market coverage and analysis of stocks and bonds begins each day at 11:45 a.m. ET.
Market Realist•last monthWill These H1 Stragglers Bounce Back in H2 2018?
Will These H1 2018 Stragglers Bounce Back in H2?Consumer packaged goods stocks underperformed in H1 2018
- GlobeNewswire•last month
Market Trends Toward New Normal in ING Group, N.V, Altaba, Steel Dynamics, The TJX Companies, Colgate-Palmolive, and Stryker — Emerging Consolidated Expectations, Analyst Ratings
NEW YORK, Aug. 09, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ING ...
Market Realist•2 months agoClorox: Analysts Reacted to the Fourth Fiscal Quarter Results
Several analysts raised their target price on Clorox (CLX) stock following the company’s fourth fiscal quarter results. Wells Fargo increased its target price to $135 per share from $123. Meanwhile, Jefferies increased its target price on Clorox to $138 per share from $124. RBC raised its target price to $134 from $130.
